Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR12W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,029
Award facts
- Contract value 100% obligated
- $12,028.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,028.78 on January 23, 2026, for the supply of Dupixent 300 mg/2 ml pen injectors with a completion date of January 26, 2026. This delivery order was competitively awarded without set-aside restrictions and carries firm fixed-price terms. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic esophagitis, representing a specialized pharmaceutical supply critical to military healthcare operations.
This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This primary IDC vehicle enables comprehensive global pharmaceutical support to military healthcare programs, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's position as a primary pharmaceutical vendor reflects its critical role in supplying essential medications to military treatment facilities and veterans' healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FR12W?
SPE2DR26FR12W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FR12W worth?
The government has obligated $12,029 on SPE2DR26FR12W.
Is contract SPE2DR26FR12W an order under another contract?
Yes. SPE2DR26FR12W is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR12W competed?
The extent of competition for SPE2DR26FR12W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award